In H. Kim

Jeonju, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 110 publications

Comparison of clinical practice guidelines for chronic hepatitis B: natural history classification and treatment initiation.

Comparison of clinical practice guidelines for chronic hepatitis B: natural history classification and treatment initiation.

Journal: Clinical and molecular hepatology
Published: June 07, 2026

Baseline neutrophil-to-eosinophil ratio and neutrophil-to-lymphocyte ratio as prognostic markers in patients with unresectable biliary tract cancer treated with gemcitabine-cisplatin-durvalumab: an international, multicentre, retrospective cohort study.

Baseline neutrophil-to-eosinophil ratio and neutrophil-to-lymphocyte ratio as prognostic markers in patients with unresectable biliary tract cancer treated with gemcitabine-cisplatin-durvalumab: an international, multicentre, retrospective cohort study.

Journal: ESMO gastrointestinal oncology
Published: May 22, 2026

KASL clinical practice guidelines for management of chronic hepatitis B Endorsed by the East Asia Liver Alliance (EALA).

KASL clinical practice guidelines for management of chronic hepatitis B Endorsed by the East Asia Liver Alliance (EALA).

Journal: Clinical and molecular hepatology
Published: May 09, 2026

Cisplatin-gemcitabine-durvalumab reintroduction in advanced biliary tract cancer: a multinational real-world analysis.

Cisplatin-gemcitabine-durvalumab reintroduction in advanced biliary tract cancer: a multinational real-world analysis.

Journal: ESMO open
Published: January 05, 2026

Current status of hepatitis C treatment and its barriers in Jeonbuk, Republic of Korea.

Current status of hepatitis C treatment and its barriers in Jeonbuk, Republic of Korea.

Journal: Osong public health and research perspectives
Published: November 23, 2025

Protective Role of Ginsenoside F1-Enriched Extract (SGB121) in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD).

Protective Role of Ginsenoside F1-Enriched Extract (SGB121) in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD).

Journal: Nutrients
Published: October 03, 2025

Pre- and postoperative predictors of extrahepatic recurrence after curative resection for hepatocellular carcinoma.

Pre- and postoperative predictors of extrahepatic recurrence after curative resection for hepatocellular carcinoma.

Journal: BMC cancer
Published: January 25, 2025

Aetiology of chronic liver disease is a valuable factor for stratifying adverse outcomes of acute decompensation: prospective observational study.

Aetiology of chronic liver disease is a valuable factor for stratifying adverse outcomes of acute decompensation: prospective observational study.

Journal: Annals of medicine
Published: January 24, 2025

Phase I Study to Evaluate the Effect of Hepatic Impairment on Pharmacokinetics and Safety of Tegoprazan, a Potassium Competitive Acid Blocker.

Phase I Study to Evaluate the Effect of Hepatic Impairment on Pharmacokinetics and Safety of Tegoprazan, a Potassium Competitive Acid Blocker.

Journal: Advances in therapy
Published: December 15, 2024

Author Correction: Etiology and clinical characteristics of acute viral hepatitis in South Korea during 2020-2021: a prospective multicenter study.

Author Correction: Etiology and clinical characteristics of acute viral hepatitis in South Korea during 2020-2021: a prospective multicenter study.

Journal: Scientific reports
Published: November 20, 2024

Correspondence to letter to the editor on "Contemporary awareness of viral hepatitis between 2012 and 2022 among Korean adults".

Correspondence to letter to the editor on "Contemporary awareness of viral hepatitis between 2012 and 2022 among Korean adults".

Journal: Clinical and molecular hepatology
Published: October 25, 2024

Albumin-Bilirubin Grade as a Valuable Predictor of Recurrence and Prognosis in Patients with Hepatocellular Carcinoma Following Radiofrequency Ablation.

Albumin-Bilirubin Grade as a Valuable Predictor of Recurrence and Prognosis in Patients with Hepatocellular Carcinoma Following Radiofrequency Ablation.

Journal: Cancers
Published: October 21, 2024
Showing 1-12 of 110

Last Updated: 09/26/2026